Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q3ZN
|
|||
| Former ID |
DIB009442
|
|||
| Drug Name |
GS-3435
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Terminated | [1] | |
| Company |
Gilead Sciences Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H19ClN4O2
|
|||
| Canonical SMILES |
CC(C)(C)OC(=O)N1CCN(CC1)C2=NC=CN=C2Cl
|
|||
| InChI |
1S/C13H19ClN4O2/c1-13(2,3)20-12(19)18-8-6-17(7-9-18)11-10(14)15-4-5-16-11/h4-5H,6-9H2,1-3H3
|
|||
| InChIKey |
IJINSJSWDSHUBL-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 313654-83-0
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Influenza Neuraminidase (Influ NA) | Target Info | Modulator | [2], [3] |
| KEGG Pathway | Other glycan degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005196) | |||
| REF 2 | US patent application no. 2010,0081,713, Compositions and methods for treating viral infections. | |||
| REF 3 | Neuraminidase inhibitors: zanamivir and oseltamivir. Ann Pharmacother. 2001 Jan;35(1):57-70. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.